Pelthos Therapeutics Inc. Company Profile
NYSE: PTHSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pelthos Therapeutics at a glance
Pelthos Therapeutics Inc. (NYSE: PTHS) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in Durham, NC. Pelthos Therapeutics is led by Mr. Scott M. Plesha and employs about 92 people. The company's shares have traded publicly since 2024.
At a market capitalization of $78.5 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001919246, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Pelthos Therapeutics do?
Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older; XEPI, (ozenoxacin) cream, a quinolone antimicrobial for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older; and XEGLYZE, a pediculicide indicated for topical treatment of head lice infestation in patients 6 months of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.
Business description based on the company's public filings.
Company information
- Legal name
- Pelthos Therapeutics Inc.
- Ticker
- NYSE: PTHS
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- CEO
- Mr. Scott M. Plesha
- Employees
- 92
- Headquarters
- 4020 Stirrup Creek Drive, Durham, NC, United States
- Phone
- 919 908 2400
- Website
- pelthos.com
- IPO year
- 2024
- Market cap
- $78.48M
- SEC CIK
- 0001919246
Companies similar to Pelthos Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| GRMLGreenland Mines Ltd. | 5.88 | +0.86% | $78.48M | vs PTHS |
| CRDFCardiff Oncology Inc. | 1.06 | -2.75% | $82.46M | vs PTHS |
| OKYOOKYO Pharma Limited | 1.39 | -2.73% | $72.95M | vs PTHS |
| CGTXCognition Therapeutics Inc. | 0.8952 | -4.42% | $85.13M | vs PTHS |
| CSBRChampions Oncology Inc. | 4.98 | +2.05% | $69.31M | vs PTHS |
| NMRANeumora Therapeutics Inc. | 0.4798 | +2.46% | $90.15M | vs PTHS |
| ATRAAtara Biotherapeutics Inc. | 9.23 | -1.49% | $92.65M | vs PTHS |
| ELOXEloxx Pharmaceuticals Inc. | 15.18 | +2.02% | $61.27M | vs PTHS |